BRIEF-Galapagos And MorphoSys Present Results From Phase 1 Study With MOR106 In Atopic Dermatitis

* GALAPAGOS AND MORPHOSYS ANNOUNCED ON SATURDAY THAT MOR106WASGENERALLY WELL TOLERATED IN ATOPIC DERMATITIS (AD) PATIENTS
The post BRIEF-Galapagos And MorphoSys Present Results From Phase 1 Study With MOR106 In Atopic Dermatitis appeared first on RocketNews | Top News Stories From Around the Globe.